Blood News and Research

RSS

Combination vaccine OK for toddlers

A University of Rochester study brings relief to new parents who, while navigating a jam-packed childhood vaccine schedule, can expect to soothe their newborn through as many as 15 "pokes" by his or her six-month checkup.

8 Oct 2007

Thalidomide therapy helps elderly myeloma patients live longer

The drug thalidomide is making a comeback as a cancer fighting therapy and has been successfully used along with standard therapy to treat the blood cancer myeloma.

7 Oct 2007

UF researchers test stem cell therapy for heart patients

University of Florida doctors on Wednesday (Oct. 3) treated their first patient enrolled in a new study designed to test whether injecting stem cells into the heart helps restore blood flow to the organ by prompting new blood vessels to grow.

4 Oct 2007

Sex after chronic heart failure

Although medication can help extend the lives of men with chronic heart failure, several factors associated with this disease can interfere with a person's ability to engage in and enjoy sexual activities.

4 Oct 2007

A systematic review of mortality in schizophrenia

As medical advances boost lifespans across the world, one group of people has been left out.

4 Oct 2007

How Candida albicans transforms from its normally benign form into life-threatening form

Researchers at the Agency for Science, Technology and Research's (A*STAR) Institute of Molecular and Cell Biology (IMCB) have discovered new molecular mechanisms that provide a more detailed understanding of how the normally benign Dr. Jekyll-like fungus known as Candida albicans transforms into a serious and often life-threatening Mr. Hyde-like form.

4 Oct 2007

Even mildly underactive thyroid doubles risk of heart conditions

Individuals with subclinical hypothyroidism - a mildly underactive thyroid only detectable by a blood test - are twice as likely to develop heart failure, compared to those with normal thyroid levels, according to a new study presented on Thursday, Oct. 4, at the 78th Annual Meeting of the American Thyroid Association (ATA) in New York.

4 Oct 2007

Discovery offers hope of halting motor neurone disease progression

Scientists have discovered a causal link between the gene for a small protein involved in the formation of blood vessels and the development of some forms of motor neurone disease.

4 Oct 2007

Specific immune deficiency pinpointed as likely cause of ulcerative colitis

In a series of mouse experiments, researchers at the Harvard School of Public Health (HSPH) have pinpointed a specific immune deficiency as the likely fundamental cause of ulcerative colitis, a chronic, sometimes severe inflammatory disease of the colon or large intestine that afflicts half a million Americans.

4 Oct 2007

Cancer cells enlist adult stem cells to promote metastasis

Everyone knows that tumors are packed with cancer cells, but many normal cells live among these deviants.

4 Oct 2007

Microvascular disease mostly a concern for women

Coronary artery disease may take a different course in men and women, which may explain why the rate of death for women has declined more slowly than for men, according to the October issue of Mayo Clinic Health Letter.

4 Oct 2007

The origin of mammalian network of lymphatic vessels

Investigators at St. Jude Children's Research Hospital settled a century-old debate on the origin of the mammalian lymphatic vasculature - the network of vessels and capillaries critical to various essential housekeeping functions in the body.

4 Oct 2007

Key to colon cancer prevention is regular screenings

More than 100,000 people will develop colon cancer in 2007, according to the American Cancer Society; the disease currently causes more than 55,000 U.S. deaths annually.

4 Oct 2007

Infant mortality rates decline in New York City

New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.

4 Oct 2007

Cancer trial combines multiple drugs to attack blood vessel formation in patients with kidney cancer

In the first clinical trial of its kind, researchers at the University of Pennsylvania School of Medicine and the Abramson Cancer Center will lead a nationwide test of anti-cancer drug combinations that target blood vessel growth in patients with advanced kidney cancer.

4 Oct 2007